Skip to main content
Equibles

JONES FINANCIAL COMPANIES LLLP

Position in EVO — Evotec SE

CIK 815917 DES PERES, MO
Back to EVO Full portfolio

Position in EVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$280
+$30 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 34 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JONES FINANCIAL COMPANIES LLLP holds $116,301,284 across 50 Drug Manufacturers - Specialty & Generic names. EVO ranks #47 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HLN
Haleon plc
 7,116,095 $66,393,166
2 ZTS
Zoetis Inc.
 191,729 $13,777,645
3 TEVA
Teva Pharmaceutical Industries Ltd
 332,250 $11,256,629
4 PBH
Prestige Consumer Healthcare Inc.
 179,743 $8,496,451
5 NBIX
Neurocrine Biosciences Inc
 33,495 $5,645,247
6 UTHR
UNITED THERAPEUTICS Corp
 4,777 $2,588,321
7 VTRS
Viatris Inc
 136,476 $2,167,238
8 AMRX
Amneal Pharmaceuticals, Inc.
 110,479 $1,912,391

All Filings in EVO

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $280 100
2026-03-31 $250 100
2025-12-31 $462 150
2025-09-30 $544 150
2025-06-30 $630 150
2025-03-31 $501 150